Jianping Xie

Combination of Nexrutine and docetaxel suppresses NFκB‐mediated activation of c‐FLIP

Wei Cheng, Addanki P. Kumar, R. Ghosh, 2017, Molecular carcinogenesis.

Diosgenin inhibits the expression of NEDD4 in prostate cancer cells.

J. Pu, Jian Chen, Jian-jun Xie, 2019, American journal of translational research.

Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity

Addanki P. Kumar, R. Ghosh, Jianping Xie, 2015, Oncotarget.

Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer

Huamin Wang, S. Kopetz, J. Freeman, 2014, Clinical Cancer Research.

Cancer Therapy : Preclinical Combined Targeting of STAT 3 / NFk B / COX-2 / EP 4 for Effective Management of Pancreatic Cancer

Huamin Wang, S. Kopetz, J. Freeman, 2014 .

Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP

Addanki P. Kumar, R. Ghosh, Jianping Xie, 2015, Molecular carcinogenesis.

Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer

P. Osmulski, Addanki P. Kumar, R. Bedolla, 2021, International journal of molecular sciences.

HLA complex group 11 is involved in colorectal carcinoma cisplatin resistance via the miR-214-5p/SOX4 axis

J. Pang, J-j Xie, Jiaping Zhu, 2021, Oncology letters.